COFORGE / Q4-FY24 / claim-ledger

Audit the questions that mattered.

Coforge · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ4-FY24 · 2024-04-24Back to quarter ↗

Questions audited

12

Answered directly

71%

Numeric claims

2

Consistency

contradicted

Question ledger

What was answered, and how?

Ravi Menon · Macquarie

direct

Will coordination with Cigniti's sales be restricted until delisting?

So, Ravi, this is Saurabh. So, see, the closing will happen when the CCI approval comes in. We expect the CCI approval to come in around 45-50 days. And once the CCI approval is done, we'll take control, we'll take board control, and post that, the synergies can be brought in.

Manik Taneja · Axis Capital

direct

Will the acquisition distract from organic growth momentum?

As far as the size of the acquisition is concerned and the impact on the organic, growth of the firm, we believe it will have no impact. We're coming in with very significant tailwind. We are coming in off a quarter where the order intake has been $774 million.

Manik Taneja · Axis Capital

direct

Will margin expansion be organic or from Cigniti?

Most of it will be organic. Our effort will be to make sure that while the PAT is the same for Cigniti, even the EBITDA over time with the AI-led offering starts replicating the Coforge EBITDA.

Vibhor Singhal · Nuvama Equities

evasive

What is the organic growth guidance for FY25?

We believe realized revenue in FY 2025, therefore, should also be reasonably closely or very closely correlated to these two numbers, 20.7, 17.3, that I talked about.

Vibhor Singhal · Nuvama Equities

direct

What is the ESOP impact on reported EBITDA margins?

We're expecting that at a reported EBITDA level, the margins to remain flat because the new ESOP scheme will come at, for the first year, which is FY 2025, come at 50-60 basis points higher than the current year.

Sandeep Shah · Equirus Securities

direct

Is there risk of revenue cannibalization from Gen AI in Cigniti's testing?

We've absolutely baked in the fact that the functional testing area is likely to be disrupted because of AI coming in. At the same time, the non-functional testing areas... have very significant upsides.

Sandeep Shah · Equirus Securities

evasive

Why no quantitative growth guidance this time?

There is absolutely no client-specific issue that we are concerned about. ... We are, in effect, offering an indirect pointer to the confidence by pointing you to order executable movement and the linkage that it's had over the last seven years with revenue recognition with realized revenue.

Dipesh Mehta · Emkay

direct

Why did gross margin expansion not materialize?

The environment continued to be tough through the year. ... the new business that came in through the year came in at a much lower margins, purely because of the lower demand that was there in the market.

Abhishek Kumar · JM Financial

partial

What kind of large deal was the $400 million BFSI deal?

The wins have been a mix of EE, EN, and NN. The $55 million deal in the current quarter that I talked about is a complete NN deal, and that's $55 million over three years alone.

Sudheer Guntupalli · Kotak Mahindra

evasive

Why no definitive growth guidance this time?

That's why we're pointing to order executable, and the fact that over a seven-year period, that's had a very strong tie-in to the revenue recognized. Hence, hence, hence the change, largely driven by the uncertainty that that is there in the environment.

Kawaljeet Saluja · Kotak Securities

direct

How to gain comfort on Cigniti's revenue quality given long tail?

When we looked at Cigniti closely, we were focused on the number of relationships that can scale up beyond $10 million in the short term... we had engaged Bain with the kind of feedback that exists about this asset.

Manik Taneja · Axis Capital

direct

Why is executable order book not moving up sharply despite strong deal wins?

So, see, when you look at our order intake in the current quarter, large deal, that is obviously for a longer period. ... We were able to kind of make sure that they don't get even a small pie of the overall contract, and we're able to lock it in.